Rapport Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $45.72 |
Previous Close | $45.49 |
Day Range | $45.51-$46.51 |
52W Range | $13.86-$48 |
Market Cap | $2.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $20M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$21.8M |
Diluted EPS | -$2.98 |
News
See moreYahoo Finance • 5 days ago
Rapport Therapeutics reports Q2 results
Yahoo Finance • 2 months ago
Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?
Yahoo Finance • 4 months ago
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
Yahoo Finance • 5 months ago
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
About
CEO | Mr. Abraham N. Ceesay M.B.A. |
Address | 99 High Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 84 |